Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masaru Mimura

Showing results (141-150 of 726) with videos related to

Pageof 73
Sort By:
Regulatory Peptides|May 11, 2010
Preliminary use of insulin-like growth factor-I as a biomarker for sorting high-dose donepezil responders among Japanese patients with Alzheimer's diseaseBun Yamagata, Takuya Watanabe, Hiroi Tomioka, et al.
Journal of Alzheimer'S Disease : JAD|March 20, 2025
A systematic review and meta-analysis on the characteristics of transcranial magnetic stimulation treatment protocols for patients with Alzheimer's diseaseKenji Fuseya, Yu Mimura, Shinichiro Nakajima, et al.
BMC Neurology|May 15, 2020
Pisa syndrome induced by switching of a choline-esterase inhibitor treatment from donepezil to galantamine: a case reportYu Mimura, Shin Kurose, Taketo Takata, et al.
Pharmacopsychiatry|January 19, 2022
Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials RegistryHitoshi Sakurai, Kengo Yonezawa, Hideaki Tani, et al.
Journal of Epidemiology|December 20, 2021
Midlife Intakes of the Isoflavone Genistein and Soy and the Risk of Late-life Cognitive Impairment: The JPHC Saku Mental Health StudyThomas Svensson, Norie Sawada, Masaru Mimura, et al.
Scientific Reports|March 2, 2016
Sleep and mood disorders in dry eye disease and allied irritating ocular diseasesMasahiko Ayaki, Motoko Kawashima, Kazuno Negishi, et al.
Pharmacopsychiatry|February 4, 2022
Drug Combinations for Mood Disorders and Physical Comorbidities That Need Attention: A Cross-Sectional National Database SurveyShin Kuramochi, Taisuke Yatomi, Takahito Uchida, et al.
Journal of Psychiatric Research|August 13, 2013
Effects of yoga therapy on postural stability in patients with schizophrenia-spectrum disorders: a single-blind randomized controlled trialSaeko Ikai, Hiroyuki Uchida, Takefumi Suzuki, et al.
PCN Reports : Psychiatry and Clinical Neurosciences|May 8, 2025
Impact of negative symptom reduction on employment and vocational activity outcomes following cognitive remediation therapy in schizophrenia: A 1-year follow-up studyYasuhisa Nakamura, Keito Shimada, Reiko Miyamoto, et al.
Human Psychopharmacology|July 25, 2014
A review on schizophrenia and relapse--a quest for user-friendly psychopharmacotherapyTakefumi Suzuki, Hiroyuki Uchida, Hiroyoshi Takeuchi, et al.
Pageof 73

Showing results (141-150 of 726) with videos related to

Sort By:
Pageof 73
Regulatory Peptides|May 11, 2010
Preliminary use of insulin-like growth factor-I as a biomarker for sorting high-dose donepezil responders among Japanese patients with Alzheimer's diseaseBun Yamagata, Takuya Watanabe, Hiroi Tomioka, et al.
Journal of Alzheimer'S Disease : JAD|March 20, 2025
A systematic review and meta-analysis on the characteristics of transcranial magnetic stimulation treatment protocols for patients with Alzheimer's diseaseKenji Fuseya, Yu Mimura, Shinichiro Nakajima, et al.
BMC Neurology|May 15, 2020
Pisa syndrome induced by switching of a choline-esterase inhibitor treatment from donepezil to galantamine: a case reportYu Mimura, Shin Kurose, Taketo Takata, et al.
Pharmacopsychiatry|January 19, 2022
Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials RegistryHitoshi Sakurai, Kengo Yonezawa, Hideaki Tani, et al.
Journal of Epidemiology|December 20, 2021
Midlife Intakes of the Isoflavone Genistein and Soy and the Risk of Late-life Cognitive Impairment: The JPHC Saku Mental Health StudyThomas Svensson, Norie Sawada, Masaru Mimura, et al.
Scientific Reports|March 2, 2016
Sleep and mood disorders in dry eye disease and allied irritating ocular diseasesMasahiko Ayaki, Motoko Kawashima, Kazuno Negishi, et al.
Pharmacopsychiatry|February 4, 2022
Drug Combinations for Mood Disorders and Physical Comorbidities That Need Attention: A Cross-Sectional National Database SurveyShin Kuramochi, Taisuke Yatomi, Takahito Uchida, et al.
Journal of Psychiatric Research|August 13, 2013
Effects of yoga therapy on postural stability in patients with schizophrenia-spectrum disorders: a single-blind randomized controlled trialSaeko Ikai, Hiroyuki Uchida, Takefumi Suzuki, et al.
PCN Reports : Psychiatry and Clinical Neurosciences|May 8, 2025
Impact of negative symptom reduction on employment and vocational activity outcomes following cognitive remediation therapy in schizophrenia: A 1-year follow-up studyYasuhisa Nakamura, Keito Shimada, Reiko Miyamoto, et al.
Human Psychopharmacology|July 25, 2014
A review on schizophrenia and relapse--a quest for user-friendly psychopharmacotherapyTakefumi Suzuki, Hiroyuki Uchida, Hiroyoshi Takeuchi, et al.
Pageof 73